跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rabeloc 20 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rabeloc 20
Approved
STANDARD
Rabeloc 20
Cadila Pharmaceuticals Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
3b19f1a3a431b416
Company
Cadila Pharmaceuticals Limited
Type
Standard
Approval Details
Approval Id
3b19f1a3a431b416
Drug Approval Philippines Name
Rabeloc 20
Product Name
Rabeloc 20
Registration Number
DRP-3833
Brand Name
Rabeloc 20
Generic Name
Rabeprazole (As Sodium)
Dosage Form
Enteric-Coated Tablet
Dosage Strength
20 mg
Manufacturer
Cadila Pharmaceuticals Limited
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Company Detail Path
/organization/cadila-pharmaceuticals-limited
Issuance Date
26 March 2021
Expiry Date
13 August 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
3b19f1a3a431b416
Type
Standard
Back to Philippines FDA Approvals